How has been the historical performance of Lincoln Pharma.?

Answer:Lincoln Pharma has shown a consistent growth trend in its historical performance over the years.

Breakdown:
The company's net sales increased from INR 366.15 crore in March 2019 to INR 623.23 crore in March 2025, reflecting a steady upward trajectory. Total operating income followed a similar pattern, rising from INR 366.15 crore in March 2019 to INR 623.23 crore in March 2025. The raw material costs also increased, from INR 113.23 crore in March 2019 to INR 213.94 crore in March 2025, while employee costs rose from INR 51.90 crore to INR 112.45 crore during the same period. Operating profit, excluding other income, showed fluctuations but generally trended upward, reaching INR 101.49 crore in March 2025, compared to INR 67.24 crore in March 2019. Profit before tax increased from INR 62.19 crore in March 2019 to INR 109.19 crore in March 2025, although profit after tax saw a peak of INR 93.30 crore in March 2024 before declining to INR 82.35 crore in March 2025. The earnings per share (EPS) also grew from INR 24.36 in March 2019 to INR 41.11 in March 2025, indicating improved profitability per share. Overall, Lincoln Pharma's financial performance demonstrates a positive growth trend in sales, profits, and earnings over the years.